Dr. Michael Zourabian, MD

Dr. Zourabian practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Zourabian's NPI, 1831304831, was assigned on May 11, 2007. Dr. Zourabian graduated from Yerevan State Medical University in 1983. Dr. Zourabian holds California license A96547.

Dr. Zourabian's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Zourabian's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Zourabian is also affiliated with USC Arcadia Hospital. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Zourabian to 2 more medical groups and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zourabian practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Zourabian's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Zourabian is board certified in family medicine by the American Board of Family Medicine. Dr. Zourabian is licensed in California.

Dmand AI lists acute skin infection, chronic anemia, contact dermatitis, fibromyalgia and chronic pain, hives, itchy rashes, joint pain and lower back pain among the conditions Dr. Zourabian treats.

CMS data shows 313 Medicare services from Dr. Zourabian across 5 procedure codes in 2024, for 309 Medicare patients. Medicare paid $39,188 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 309 Medicare patients who saw Dr. Zourabian in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zourabian's median patient age at 65, with 54% women.

In 2024, Dr. Zourabian wrote 135 Medicare Part D claims for 107 patients. 91% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $146 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Zourabian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Zourabian from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $45.

Dr. Zourabian graduated from Yerevan State Medical University in 1983.

Dr. Zourabian is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.